USFDA APPLICATION NUMBER - 22281 / DOSAGE - CAPSULE;ORAL - 20MG;1.1GM
Active Ingredient/Active Moiety | ||
Ingredient Name | Basis of Strength | Strength |
---|---|---|
OMEPRAZOLE(UNII: KG60484QX9) (OMEPRAZOLE - UNII:KG60484QX9) | OMEPRAZOLE | 20mg |
SODIUM BICARBONATE(UNII: 8MDF5V39QO) (BICARBONATE ION - UNII:HN1ZRA3Q20) | SODIUM BICARBONATE | 1100mg |
Inactive Ingredients
Ingredient Name | Akron Pharma Inc | AvKARE, Inc. | Cipla USA Inc. | Medarbor Llc | Par Pharmaceutical Inc. | Dr.Reddy's Laboratories Limited | Bayer HealthCare LLC | Guardian Drug Company | Northstar Rx LLC | HyVee Inc | Topco Associates LLC |
---|---|---|---|---|---|---|---|---|---|---|---|
ALCOHOL(3K9958V90M) | |||||||||||
AMMONIA(5138Q19F1X) | |||||||||||
BUTYL ALCOHOL(8PJ61P6TS3) | |||||||||||
CROSCARMELLOSE SODIUM(M28OL1HH48) | |||||||||||
D&C YELLOW NO. 10(35SW5USQ3G) | |||||||||||
FD&C BLUE NO. 1(H3R47K3TBD) | |||||||||||
FD&C BLUE NO. 2(L06K8R7DQK) | |||||||||||
FD&C RED NO. 3(PN2ZH5LOQY) | |||||||||||
FD&C RED NO. 40(WZB9127XOA) | |||||||||||
FERROSOFERRIC OXIDE(XM0M87F357) | |||||||||||
GELATIN(2G86QN327L) | |||||||||||
GELATIN, UNSPECIFIED(2G86QN327L) | |||||||||||
ISOPROPYL ALCOHOL(ND2M416302) | |||||||||||
MAGNESIUM STEARATE(70097M6I30) | |||||||||||
POLYSORBATE 80(6OZP39ZG8H) | |||||||||||
POTASSIUM HYDROXIDE(WZH3C48M4T) | |||||||||||
PROPYLENE GLYCOL(6DC9Q167V3) | |||||||||||
SHELLAC(46N107B71O) | |||||||||||
SHELLAC(MB5IUD6JUA) | |||||||||||
silicon dioxide(ETJ7Z6XBU4) | |||||||||||
SODIUM LAURYL SULFATE(368GB5141J) | |||||||||||
SODIUM STEARYL FUMARATE(7CV7WJK4UI) | |||||||||||
SODIUM(9NEZ333N27) | |||||||||||
titanium dioxide(15FIX9V2JP) |